Entera Bio ENTX
NASDAQ ENTX
$3.22 -0.02 (-0.62%)
At close: Nov 11, 2026 · 4:00 PM EST

Entera Bio (ENTX) Preferred Stock Liabilities (2018 - 2021)

Updated

Analysis

Entera Bio (ENTX) Preferred Stock Liabilities (2018 - 2021) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Stock Liabilities (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Entera Bio 563.51 Mn 269.58 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2021 698,000.00
Jun 30, 2021 1.40 Mn
Mar 31, 2021 8.54 Mn
Dec 31, 2020 1.43 Mn
Sep 30, 2020 1.55 Mn
Jun 30, 2020 2.35 Mn
Mar 31, 2020 2.71 Mn
Dec 31, 2019 2.44 Mn
Sep 30, 2019 700,000.00
Jun 30, 2019 578,000.00
Mar 31, 2019 1.26 Mn
Dec 31, 2018 1.37 Mn
API Access

Entera Bio Preferred Stock Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=preferred-stock-liabilities&ticker=ENTX&period=max&api_key=YOUR_API_KEY